Claudio Rapezzi

Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases

Perry Elliott, B. Andersson, Eloisa Arbustini et al. · European Heart Journal · 2007 · 3K citations · Full text

Medicine, Cardiology, Clinical Cardiology +8

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Jeffrey H. Schwartz, Balarama Gundapaneni, Perry Elliott et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Julian D. Gillmore, Rodney H. Falk, Giampaolo Merlini et al. · Circulation · 2016 · 2K citations · Full text

Medicine, Cardiology, Nuclear Medicine +14

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

Constantinos O’Mahony, Fatima Jichi, Menelaos Pavlou et al. · European Heart Journal · 2013 · 1.2K citations · Full text

Business, Biostatistics, Cardiology +17

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Pablo García‐Pavía, Claudio Rapezzi, Yehuda Adler et al. · European Heart Journal · 2021 · 1.1K citations · Full text

Medicine, Cardiology, Pathology +16